Form 4: Precigen's Chief Legal Officer Granted 125,000 Restricted Stock Units

Donald P. Lehr, Chief Legal Officer of Precigen, Inc., was granted 125,000 restricted stock units (RSUs) on June 26, 2025, as part of his compensation.

Summary

• Donald P. Lehr, the Chief Legal Officer of Precigen, Inc. (PGEN), was granted 125,000 Restricted Stock Units (RSUs).
• The transaction date for this grant was June 26, 2025.
• Each RSU represents a contingent right to receive one share of Precigen common stock.
• The RSUs will vest 50% on May 23, 2026, with the remaining portion vesting in equal monthly installments over the subsequent three years.
• Following this transaction, Donald P. Lehr beneficially owns 125,000 derivative securities in the form of RSUs.

Sentiment

Score: 7

Explanation: The grant of RSUs to a key executive is generally a positive signal, indicating management retention and alignment of interests, though it implies future dilution. The transaction itself is routine for executive compensation.

Positives

• The grant of 125,000 Restricted Stock Units to the Chief Legal Officer serves as an incentive and retention mechanism for key management.
• The vesting schedule aligns the executive's long-term interests with the company's performance over several years.

Risks

• The future conversion of RSUs into common stock will result in dilution for existing shareholders, although this is a standard component of equity compensation plans.

Future Outlook

The granted Restricted Stock Units are scheduled to vest over a period extending beyond May 23, 2026, with the remaining 50% vesting in equal monthly installments for three years thereafter, indicating a long-term incentive structure for the Chief Legal Officer.

Industry Context

This Form 4 filing reflects a routine equity compensation grant to a senior executive, a common practice across various industries, including biotechnology and pharmaceuticals, to align management incentives with shareholder value creation and ensure executive retention.

Stakeholder Impact

• Shareholders: Potential for minor future dilution as RSUs convert to common stock, but also benefit from incentivized executive performance.
• Employees (specifically Donald P. Lehr): Significant increase in long-term equity compensation, aligning personal financial interests with company success.

Next Steps

• The vesting of the granted Restricted Stock Units will commence with 50% on May 23, 2026, followed by equal monthly installments for three years thereafter.

Key Dates

Keywords

Precigen, PGEN, Restricted Stock Units, RSU, SEC Form 4, Insider Transaction, Equity Compensation, Chief Legal Officer, Donald P. Lehr